Brief: The Carlyle Group Inc Reports 6.2% Stake In Soleno Therapeutics As Of Oct 10 Versus 8.1% As Of Oct 8 - SEC Filing
Oct 15 (Reuters) - Carlyle Group Inc CG.O :
* THE CARLYLE GROUP INC REPORTS 6.2% STAKE IN SOLENO
THERAPEUTICS
AS OF OCT 10 VERSUS 8.1% AS OF OCT 8 - SEC FILING
Source text for Eikon: ID:n0001193125-24-237617
Further company coverage: CG.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Soleno Therapeutics
See all newsNASDAQ TRADE HALT REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: EMA's CHMP Recommends Granting A Marketing Authorisation For Cenrifki (Tolebrutinib)